Dr. Mikhael is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10510 N 92nd Street Suite 200
Scottsdale, AZ 85258Phone+1 480-323-1350
Education & Training
University of Ottawa Faculty of MedicineClass of 1997
Certifications & Licensure
AZ State Medical License 2007 - 2025
Clinical Trials
- Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction Start of enrollment: 2009 Jan 21
- Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma Start of enrollment: 2009 Jun 01
- Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma.Luciano J Costa, Rahul Banerjee, Hira Mian, Katja Weisel, Susan Bal
Leukemia. 2025-01-27 - Down with dex!Susan Harding, Joseph Mikhael
Blood. 2025-01-02 - Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies.Paul G Richardson, Aurore Perrot, Joseph Mikhael, Thomas Martin, Meral Beksac
Blood Cancer Journal. 2024-11-28
Abstracts/Posters
- The Global State of Hematopoietic Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Datab...Joseph Mikhael, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Relationship between Baseline Biomarkers and Efficacy of Isatuximab in Combination with Pomalidomide and Dexamethasone in RRMM: Insights from Phase 1 and Phase 3 S...Joseph Mikhael, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Show Me the Money: Negotiating Your First Job60th American Society of Hematology Annual Meeting - 11/30/2018
- Real-world evidence of cardiac hospitalizations in carfilzomib- and non-carfilzomib-treated multiple myeloma patients in the United States.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Join now to see all
Press Mentions
Janssen Launches Health Equity Campaign in Partnership with Award-Winning Radio Host D.L. Hughley to Raise Awareness About Multiple Myeloma Among Black CommunitiesMarch 2nd, 2023- City of Hope Researchers Present Innovative Studies at American Society of Hematology (ASH) Annual MeetingDecember 13th, 2022
- FDA Approves New CAR T Cancer Therapy for Form of Multiple MyelomaFebruary 28th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
